DCB in PCI: Adjunctive Therapy or Standard of Care?
Published: 14 February 2022
-
Views:
25710
-
Likes:
7
Overview
Full programme
-
Views:
25710
-
Likes:
7
Part 1 of 2
Next > Episode 2: The benefits vs DES and PTX vs Limus
Overview
Learn more about the origins and science behind the DCB technology, the important clinical data supporting DCB use in the coronary arteries, existing and emerging treatment indications through videos, interviews and panel discussions with renowned faculty from highly ranked institutions.
This programme is supported by: Medtronic

Key Learning Objectives
- To discuss the origins and science behind the DCB technology, its current and potential areas of application in various clinical scenarios, and emphasize the benefits of DCB technology vs DES and Paclitaxel vs Limus.
- To emphasize the importance of vessel preparation, algorithms of optimal therapy delivery and criteria used for immediate results evaluation.
- To highlight the DCB Clinical Program, understanding the clinical benefits and safety of paclitaxel DCBs, and its relevance to your daily practice
Target Audience
- Interventional Cardiologists
- General Cardiologists
- Allied Healthcare Professionals
More from this programme
Part 1
Science of DCB
In episode, both physicians will discuss the origins behind the drug-coated balloons (DCBs) technology. One of the fathers of DCB technology Prof Bruno Scheller, will share a fascinating story about how a bit of luck and solid experimentation had a tremendous impact on what is now seen as a very exciting new era in cardiology. Followed by episode 2, Prof. Scheller and Dr Tunev delve into an important discussion around the benefits of DCBs vs DES and PTX vs Limus, providing insights on DCB mechanisms of action and predictors of long-tern efficacy. Questions 1: How do DCBs work in the vessel? Question 2: What are the benefits of DCB vs DES? Question 3: What is the difference between the two drugs in the context of DCB?
Part 2
DCB: Role of Predilatation and dissection assessment
This episode sheds light on very important steps of the DCB-alone PCI - lesion preparation and dissection assessment. Prof. Scheller and Dr. Mylote discuss how their practice has evolved in terms of preparing the lesion for treatment with a DCB, and share their recommendations how to manage different types of dissections.
Faculty Biographies

Bruno Scheller
Dr Bruno Scheller studied medicine at the University of Saarland, Germany, from 1988 til 1994.

Stefan Tunev
Veterinary Pathologist, Fellow in Comparative Medicine, specializing in the field of medical device pathology